Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin

Area of Science:

• Oncology
• Proteomics
• Biochemistry

Background:

• Cancer-derived extracellular vesicles (EVs) are implicated in promoting tumor growth and metastasis through their protein cargo.
• Identifying the specific proteins packaged by tumors into EVs in vivo is challenging due to the presence of EVs from other tissues.

Purpose of the Study:

• To develop and validate a cross-species proteomic method for quantifying human tumor-derived proteins within plasma EVs.
• To investigate the protein cargo of EVs from patient-derived xenografts (PDXs) across different cancer types.
• To assess the potential of EV protein cargo for cancer type classification.

Main Methods:

• Utilized patient-derived xenografts (PDXs) from four cancer types in a cross-species model.
• Applied advanced proteomic profiling to quantify the human tumor-derived proteome within plasma EVs.
• Employed machine learning algorithms to analyze proteomic data for cancer classification.

Main Results:

• Demonstrated individualized and novel protein cargo packaging within tumor-derived EVs.
• Successfully classified the underlying tumor type based on the proteomic signature of plasma EVs.
• Validated the efficacy of the cross-species proteomic approach.

Conclusions:

• The developed cross-species proteomic method effectively identifies tumor-specific EV protein cargo.
• EV protein cargo analysis holds significant potential for non-invasive cancer diagnostics and classification.
• This approach offers a novel strategy to understand EV-mediated cancer progression.